Nucleotide excision repair genes and lung cancer risk: A pathway-based approach
jian gu,yunfei wang,jie lin,maosheng huang,qiong dong,margaret r spitz,xifeng wu
IF: 11.2
2005-01-01
Cancer Research
Abstract:Proc Amer Assoc Cancer Res, Volume 46, 2005 2560 Nucleotide excision repair (NER) is one of the major DNA repair pathways in mammalian cells, involved in the removal of a wide variety of DNA lesions including bulky carcinogen adducts from tobacco exposure. Polymorphisms in NER genes may influence DNA repair capacity and confer cancer susceptibility. To explore the association between these polymorphisms and lung cancer risk, we examined ten polymorphisms in six major NER genes in 1396 lung cancer patients and 1423 age-, gender- and smoking-matched controls. The specific polymorphic loci examined include: XPA (A/G at 5’ UTR), XPC (polyAT, Ala499Val, Lys939Gln), XPD (Asp312Asn, Lys751Gln), XPF (Ser662Pro), XPG (His1104Asp), ERCC6 (Met1097Val, Arg1230Pro). For main effects of the individual polymorphisms, only the variant XPA alleles had a significant impact on lung cancer risk (OR=0.80, 95%: 0.64-0.99). There were no statistically significant differences in the distributions of the other polymorphisms between the cases and the controls. However, there was a significant trend for an increased risk of lung cancer with an increasing number of putative high-risk alleles. Using individuals with less than 3 putative high-risk alleles as the reference group, individuals with 3, 4 and more than 4 risk alleles had adjusted ORs of 1.14 (0.87-1.49), 1.40 (1.08-1.81) and 1.68 (1.32-2.12), respectively, ( P for trend < 0.000). When we dichotoimized the subjects at ≥4 or <4 putative risk alleles, individuals with ≥4 risk alleles had a significantly elevated lung cancer risk (OR=1.46, 95%: 1.24-1.73) as compared to those with <4 risk alleles. The risk was more evident in men (OR=1.72, 95%: 1.35-2.18) compared to women (OR=1.25, 95%: 0.98-1.58); in younger individuals (OR=1.63, 95%: 1.27-2.09) compared to older individuals (OR=1.31, 95%: 1.04-1.65); in ever smokers (OR=1.52, 95%: 1.27-1.81) compared to never smokers (OR=1.11, 95%: 0.74-1.81); and in heavy smokers (OR=1.88, 95%: 1.48-2.39) compared to light smokers (OR=1.14, 95%: 0.90-1.45). This large study offers a pathway-based analysis of multiple polymorphic genes and the data suggest that individuals with higher number of genetic variations in DNA repair genes in a common pathway are at increased risk for lung cancer, confirming the importance of taking a pathway-based approach to risk assessment. Supported by NCI grants CA 55769, CA 70907 and CA 86390 .